Menu

 

Letter

Response: Roche

Roche replies to the authors of the Cochrane Review on oseltamivir

BMJ 2009; 339 doi: http://dx.doi.org/10.1136/bmj.b5364 (Published 8 December 2009)
Cite this as: BMJ 2009;339:b5364

Related articles

Feature: Search for evidence goes on

Published 17 January 2012; BMJ 344 doi: 10.1136/bmj.e458

Research: Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis

Published 8 December 2009; BMJ 339 doi: 10.1136/bmj.b5106

Letter: Point-by-point response from Roche to BMJ questions

Published 8 December 2009; BMJ 339 doi: 10.1136/bmj.b5374

Feature: Complications: tracking down the data on oseltamivir

Published 8 December 2009; BMJ 339 doi: 10.1136/bmj.b5387

Editorial: Why don’t we have all the evidence on oseltamivir?

Published 8 December 2009; BMJ 339 doi: 10.1136/bmj.b5351

See more

Research: Risk of incident diabetes among patients treated with statins: population based study

Published 23 May 2013; BMJ 346 doi: 10.1136/bmj.f2610

Editorial: Statins and the risk of developing diabetes

Published 23 May 2013; BMJ 346 doi: 10.1136/bmj.f3156

Feature: The long road to ensuring patient safety in NHS hospitals

Published 23 May 2013; BMJ 346 doi: 10.1136/bmj.f3029

Practice: Pelvic inflammatory disease

Published 23 May 2013; BMJ 346 doi: 10.1136/bmj.f3189

This article has been cited by other articles:

Latest comments and most commented

THIS WEEK'S POLL

Read related article

See previous polls